# Antiviral Therapy in Infants With HBV Infection

> **NCT06503796** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Beijing 302 Hospital** · enrollment: 60 (estimated)

## Conditions studied

- HBV

## Interventions

- **DRUG:** Lamivudine
- **DRUG:** Interferon

## Key facts

- **NCT ID:** NCT06503796
- **Lead sponsor:** Beijing 302 Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-08
- **Primary completion:** 2025-11
- **Final completion:** 2026-11
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2024-07-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06503796

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06503796, "Antiviral Therapy in Infants With HBV Infection". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06503796. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*